{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T13:59:57Z","timestamp":1697637597106},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[1996]]},"DOI":"10.1080\/00313029600169523","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T22:21:40Z","timestamp":1128637300000},"page":"51-53","source":"Crossref","is-referenced-by-count":4,"title":["Donor leukocyte infusions in the treatment of chronic myeloid leukemia in relapse post bone marrow transplantation"],"prefix":"10.1016","volume":"28","author":[{"given":"Geoffrey R.","family":"Hill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek N.J.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea F.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1080\/00313029600169523_bib1095","doi-asserted-by":"crossref","first-page":"254","DOI":"10.7326\/0003-4819-122-4-199502150-00003","article-title":"Prolonged survival in chronic myelogenous leukemia after cytogenic response to interferon \u03b1 therapy","volume":"122","author":"Kantarjian","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1080\/00313029600169523_bib1100","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJM199403243301204","volume":"330","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1080\/00313029600169523_bib1105","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1200\/JCO.1987.5.7.1033","article-title":"Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation","volume":"5","author":"McGlave","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1080\/00313029600169523_bib1110","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/0003-4819-104-2-155","article-title":"Marrow transplantation for the treatment of chronic myelogenous leukemia","volume":"104","author":"Thomas","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1080\/00313029600169523_bib1115","doi-asserted-by":"crossref","first-page":"806","DOI":"10.7326\/0003-4819-108-6-806","article-title":"Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk of relapse associated with T-cell depletion","volume":"108","author":"Goldman","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1080\/00313029600169523_bib1120","first-page":"379","article-title":"Long term follow-up after bone marrow transplantation for chronic myelogenous leukemia: factors associated with relapse","volume":"5","author":"Devergie","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/00313029600169523_bib1125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1056\/NEJM199401133300204","article-title":"Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia","volume":"330","author":"Porter","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1080\/00313029600169523_bib1130","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1200\/JCO.1994.12.8.1710","article-title":"Leukemia: management of relapse after altogeneic bone marrow transplantation","volume":"12","author":"Kumar","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1080\/00313029600169523_bib1135","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","article-title":"Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients","volume":"76","author":"Kolb","year":"1990","journal-title":"Blood"},{"key":"10.1080\/00313029600169523_bib1140","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood.V83.11.3377.3377","article-title":"Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse","volume":"83","author":"van Rhee","year":"1994","journal-title":"Blood"},{"key":"10.1080\/00313029600169523_bib1145","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1200\/JCO.1993.11.3.513","article-title":"Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation","volume":"11","author":"Bar","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1080\/00313029600169523_bib1150","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/00007890-199311000-00013","article-title":"Interferon-\u03b1 and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation","volume":"56","author":"Hertenstein","year":"1993","journal-title":"Transplantation"},{"key":"10.1080\/00313029600169523_bib1155","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood.V82.8.2310.2310","article-title":"Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose","volume":"82","author":"Drobyski","year":"1993","journal-title":"Blood"},{"key":"10.1080\/00313029600169523_bib1160","first-page":"37","article-title":"Adoptive immunotherapy in human and canine chimeras: the role of interferon alpha","volume":"30","author":"Kolb","year":"1993","journal-title":"Seminars in Hematology"},{"key":"10.1080\/00313029600169523_bib1165","first-page":"301","article-title":"Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation","volume":"10","author":"Drobyski","year":"1992","journal-title":"Bone Marrow Transplantation"},{"key":"10.1080\/00313029600169523_bib1170","first-page":"269","article-title":"Second HLA-identical sibling transplants for leukemia recurrence","volume":"9","author":"Mrsic","year":"1992","journal-title":"Bone Marrow Transplantation"},{"key":"10.1080\/00313029600169523_bib1175","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood.V85.9.2632.bloodjournal8592632","article-title":"Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myetoid leukemia: results and implications in 346 patients","volume":"85","author":"Radich","year":"1995","journal-title":"Blood"},{"key":"10.1080\/00313029600169523_bib1180","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood.V82.8.2273.2273","article-title":"Graft-versus-leukemia: no longer an epiphenomenon","volume":"82","author":"Antin","year":"1993","journal-title":"Blood"},{"key":"10.1080\/00313029600169523_bib1185","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions","volume":"15","author":"Kolb","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"10.1080\/00313029600169523_bib1190","first-page":"109","article-title":"Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukemia following allogeneic BMT","volume":"11","author":"Szer","year":"1993","journal-title":"Bone Marrow Transplantation"},{"key":"10.1080\/00313029600169523_bib1195","first-page":"331","article-title":"Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation","volume":"14","author":"Ferster","year":"1994","journal-title":"Bone Marrow Transplantation"},{"key":"10.1080\/00313029600169523_bib1200","article-title":"Adoptive immunotherapy using escalating doses of donor leukocytes for relapsed CML following allogeneic BMT","volume":"15","author":"Mackinnon","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"10.1080\/00313029600169523_bib1205","series-title":"Graft-vs-host disease: immunology, pathophysiology and treatment","first-page":"177","article-title":"Graft-vs-leukemia effect","author":"Truitt","year":"1990"},{"key":"10.1080\/00313029600169523_bib1210","first-page":"181","article-title":"In vitro separation of host specific graft-versus-host and grm\u2019t-versus-leukemia cytotoxic T cell activities","volume":"10","author":"van Lochem","year":"1992","journal-title":"Bone Marrow Transplantation"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516352199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516352199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T05:47:53Z","timestamp":1586497673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516352199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996]]}},"alternative-id":["S0031302516352199"],"URL":"https:\/\/doi.org\/10.1080\/00313029600169523","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[1996]]}}}